Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896479511> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2896479511 endingPage "e187" @default.
- W2896479511 startingPage "e187" @default.
- W2896479511 abstract "IL-6 increases tumorigenic potential of primary human cancer stem cells. The goal of our study was to determine if an IL-6 receptor antibody (Tocilizumab) has an impact on tumor growth. IACUC approval was obtained before starting the experiments. The HNSCC cell line UT-SCC-14 was used for all experiments. A MTT assay was used to establish any effect of tocilizumab on cell growth. The effect of tocilizumab on clonogenic survival was also assessed. In the first set of experiments, a four armed study looked at tumor volume of flank tumors treated with a sham antibody (sham), tocilizumab (TOC), radiation (RT), and tocilizumab + radiation (TOC + RT). In the second set of experiments, a three arm study looked at flow cytometry stained for aldehyde dehydrogenase (ALDH) and CD44 at day 22, 30, and 43 with TOC, RT, TOC + RT for ex-vivo flank tumors. There was no significant difference in clonogenic survival in TOC versus the control. There was also no correlation with increasing concentration of TOC. In experiment 1, the TOC + RT had significantly smaller tumor volumes compared to the RT alone group at days 25 and 37 while trended for smaller tumor volumes at days 29 and 32. In experiment 2, the TOC + RT had significantly smaller tumor volumes compared to the RT alone group at days 31 and 35. On flow cytometry, ALDH(+) CD44(-) population significantly increased during day 30 in the TOC + RT group compared to both the TOC alone and RT alone. IL-6 receptor antibody has no effect on in vitro cell survival but does impact in vivo repopulation with an increase in non-cancer stem cells. Further studies are necessary to validate improvement with chemotherapy." @default.
- W2896479511 created "2018-10-26" @default.
- W2896479511 creator A5006868043 @default.
- W2896479511 creator A5017369915 @default.
- W2896479511 creator A5017468691 @default.
- W2896479511 creator A5034249319 @default.
- W2896479511 creator A5040457125 @default.
- W2896479511 creator A5079966600 @default.
- W2896479511 date "2018-11-01" @default.
- W2896479511 modified "2023-10-01" @default.
- W2896479511 title "IL-6 Receptor Antibody Preferentially Affects Tumors in the Repopulation Phase of Growth" @default.
- W2896479511 doi "https://doi.org/10.1016/j.ijrobp.2018.07.681" @default.
- W2896479511 hasPublicationYear "2018" @default.
- W2896479511 type Work @default.
- W2896479511 sameAs 2896479511 @default.
- W2896479511 citedByCount "0" @default.
- W2896479511 crossrefType "journal-article" @default.
- W2896479511 hasAuthorship W2896479511A5006868043 @default.
- W2896479511 hasAuthorship W2896479511A5017369915 @default.
- W2896479511 hasAuthorship W2896479511A5017468691 @default.
- W2896479511 hasAuthorship W2896479511A5034249319 @default.
- W2896479511 hasAuthorship W2896479511A5040457125 @default.
- W2896479511 hasAuthorship W2896479511A5079966600 @default.
- W2896479511 hasBestOaLocation W28964795111 @default.
- W2896479511 hasConcept C117262875 @default.
- W2896479511 hasConcept C142724271 @default.
- W2896479511 hasConcept C1491633281 @default.
- W2896479511 hasConcept C159654299 @default.
- W2896479511 hasConcept C190283241 @default.
- W2896479511 hasConcept C203014093 @default.
- W2896479511 hasConcept C2777178219 @default.
- W2896479511 hasConcept C2779134260 @default.
- W2896479511 hasConcept C2780932548 @default.
- W2896479511 hasConcept C2908647359 @default.
- W2896479511 hasConcept C502942594 @default.
- W2896479511 hasConcept C54355233 @default.
- W2896479511 hasConcept C553184892 @default.
- W2896479511 hasConcept C55493867 @default.
- W2896479511 hasConcept C71924100 @default.
- W2896479511 hasConcept C86803240 @default.
- W2896479511 hasConcept C99454951 @default.
- W2896479511 hasConceptScore W2896479511C117262875 @default.
- W2896479511 hasConceptScore W2896479511C142724271 @default.
- W2896479511 hasConceptScore W2896479511C1491633281 @default.
- W2896479511 hasConceptScore W2896479511C159654299 @default.
- W2896479511 hasConceptScore W2896479511C190283241 @default.
- W2896479511 hasConceptScore W2896479511C203014093 @default.
- W2896479511 hasConceptScore W2896479511C2777178219 @default.
- W2896479511 hasConceptScore W2896479511C2779134260 @default.
- W2896479511 hasConceptScore W2896479511C2780932548 @default.
- W2896479511 hasConceptScore W2896479511C2908647359 @default.
- W2896479511 hasConceptScore W2896479511C502942594 @default.
- W2896479511 hasConceptScore W2896479511C54355233 @default.
- W2896479511 hasConceptScore W2896479511C553184892 @default.
- W2896479511 hasConceptScore W2896479511C55493867 @default.
- W2896479511 hasConceptScore W2896479511C71924100 @default.
- W2896479511 hasConceptScore W2896479511C86803240 @default.
- W2896479511 hasConceptScore W2896479511C99454951 @default.
- W2896479511 hasIssue "3" @default.
- W2896479511 hasLocation W28964795111 @default.
- W2896479511 hasOpenAccess W2896479511 @default.
- W2896479511 hasPrimaryLocation W28964795111 @default.
- W2896479511 hasRelatedWork W2086906150 @default.
- W2896479511 hasRelatedWork W2149506092 @default.
- W2896479511 hasRelatedWork W2328420327 @default.
- W2896479511 hasRelatedWork W2349088748 @default.
- W2896479511 hasRelatedWork W2353621674 @default.
- W2896479511 hasRelatedWork W2890284775 @default.
- W2896479511 hasRelatedWork W2910797523 @default.
- W2896479511 hasRelatedWork W2954920189 @default.
- W2896479511 hasRelatedWork W3092521275 @default.
- W2896479511 hasRelatedWork W4313704705 @default.
- W2896479511 hasVolume "102" @default.
- W2896479511 isParatext "false" @default.
- W2896479511 isRetracted "false" @default.
- W2896479511 magId "2896479511" @default.
- W2896479511 workType "article" @default.